Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News SCYNEXIS Inc SCYX

Healthcare
SCYNEXIS, Inc. is a biotechnology company. It is pioneering medicine to overcome and prevent difficult-to-treat and drug-resistant infections. It develops antifungal platform fungerps, a novel class of antifungal agents called triterpenoids, that are structurally distinct glucan synthase inhibitors and have generally shown in vitro and in vivo activity against a range of human fungal pathogens,... see more

Recent & Breaking News (NDAQ:SCYX)

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of SCYNEXIS, Inc. - SCYX

PR Newswire December 28, 2023

ROSEN, RESPECTED INVESTOR COUNSEL, Encourages SCYNEXIS, Inc. Investors to Secure Counsel Before Important January 8 Deadline in Securities Class Action - SCYX

Newsfile December 28, 2023

SCYX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Reminds Scynexis, Inc. Investors with Substantial Losses to Actively Participate in the Class Action Lawsuit!

Accesswire December 28, 2023

INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in SCYNEXIS, Inc. with Losses of $100,000 to Contact the Firm

Newsfile December 28, 2023

SCYX Investors Have Opportunity to Lead SCYNEXIS, Inc. Securities Fraud Lawsuit

PR Newswire December 28, 2023

SCYNEXIS INVESTOR DEADLINE APPROACHING: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $25,000 In Scynexis To Contact Him Directly To Discuss Their Options

PR Newswire December 28, 2023

Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of SCYNEXIS, Inc. (SCYX) Investigation

Accesswire December 28, 2023

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in SCYNEXIS, Inc. with Losses of $100,000 to Contact the Firm

Accesswire December 28, 2023

ROSEN, A LEADING LAW FIRM, Encourages SCYNEXIS, Inc. Investors with Losses to Secure Counsel Before Important January 8 Deadline in Securities Class Action - SCYX

Newsfile December 27, 2023

SCYX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Reminds Scynexis, Inc. Investors with Substantial Losses to Actively Participate in the Class Action Lawsuit!

Accesswire December 27, 2023

INVESTOR ACTION REMINDER: The Schall Law Firm Encourages Investors in SCYNEXIS, Inc. with Losses of $100,000 to Contact the Firm

Newsfile December 27, 2023

Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of SCYNEXIS, Inc. (SCYX) Investigation

Accesswire December 27, 2023

INVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in SCYNEXIS, Inc. with Losses to Contact the Firm

Accesswire December 26, 2023

SCYX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Reminds Scynexis, Inc. Investors with Substantial Losses to Actively Participate in the Class Action Lawsuit!

Accesswire December 26, 2023

INVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in SCYNEXIS, Inc. with Losses of $100,000 to Contact the Firm

Newsfile December 26, 2023

Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of SCYNEXIS, Inc. (SCYX) Investigation

Accesswire December 26, 2023

TOP RANKED ROSEN LAW FIRM Encourages SCYNEXIS, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SCYX

PR Newswire December 25, 2023

ROSEN, LEADING INVESTOR COUNSEL, Encourages SCYNEXIS, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SCYX

TheNewsWire December 25, 2023

SCYX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Reminds Scynexis, Inc. Investors with Substantial Losses to Actively Participate in the Class Action Lawsuit!

Accesswire December 25, 2023

Scynexis Deadline Alert

Newsfile December 25, 2023